Stem Cell Therapy
SKU
MRR-431752EA49AD
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 439.83 million
2030
USD 1,027.44 million
2024
USD 493.23 million
CAGR
12.88%

Stem Cell Therapy Market by Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Cell Source (Adipose Tissue-Derived MSCs, Bone Marrow-Derived MSCs, Placental / Umbilical Cord-Derived MSCs), Therapeutic Application, End-User - Global Forecast 2024-2030

[193 Pages Report] The Stem Cell Therapy Market size was estimated at USD 439.83 million in 2023 and expected to reach USD 493.23 million in 2024, at a CAGR 12.88% to reach USD 1,027.44 million by 2030.

Stem Cell Therapy Market
To learn more about this report, request a free PDF copy

Stem cell therapy refers to the medical use of stem cells to replace and repair damaged or diseased tissue or organs. This therapy is important in treating various diseases, including Parkinson's, Alzheimer's, diabetes, and heart disease, by stimulating the body's repair mechanisms. Stem cells can potentially develop many different cell types in the body during early life and growth. The prevalence of chronic diseases and favorable government initiatives for regenerative treatments worldwide boost the need for stem cell therapy. However, the concerns associated with the high cost, stringent regulations, and approval processes are a significant challenge for the key players. Companies are trying to comply with the robust standards imposed by the governments to remain agile within the spaces. Moreover, the advancements in regenerative therapy and the continuous research and development activities in stem cell therapy contribute to the future expansion of key players.

Stem Cell Therapy Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Type: Increasing uses of allogeneic and autologous stem cell therapy in chronic disease treatments

Allogeneic stem cell therapy involves the transplantation of stem cells from a donor to another recipient. This therapy is often preferred in conditions for patients with cells unsuitable for therapy, such as in cases with genetic disorders. It also allows for off-the-shelf solutions, leading to rapidness in treatment administration. On the other hand, autologous stem cell therapy uses a patient's stem cells collected from their bone marrow, adipose tissue, and blood. This type of therapy is associated with a lower risk of immune rejection since the cells are derived from the patient's body.

Cell Source: Rising adoption of AD-MSCs and BM-MSCs in tissue remodeling and tissue repairing

Adipose tissue-derived mesenchymal stem cells (AD-MSCs) are obtained from adipose tissue, commonly known as body fat. These cells are of significant interest due to their relative ease of access. The extraction of AD-MSCs involves less invasive procedures than other sources and can be done under local anesthesia via liposuction. AD-MSCs are used in various therapeutic approaches because they differentiate into multiple cell types, secrete growth factors, and modulate immune responses. At the same time, bone marrow-derived mesenchymal stem cells (BM-MSCs) are harvested from the bone marrow, typically from the iliac crest of the pelvis. They are among the extensively studied stem cells with known potential to differentiate into bone, cartilage, and adipose tissue. BM-MSCs also have robust immunomodulatory properties, making them prominent candidates for treating autoimmune diseases and supporting engraftment in bone marrow transplantation. While, placental and umbilical cord-derived mesenchymal stem cells (PC-UC-MSCs) are obtained from the placenta and the umbilical cord following childbirth. These cells are non-invasive to collect and have a higher proliferation rate than adult stem cells, such as AD-MSCs and BM-MSCs.

Therapeutic Application: Growing popularity of regenerative medicine in varied therapeutics areas

Stem cells are being explored as a revolutionary option in the treatment of various cardiovascular diseases, including myocardial infarction and congestive heart failure. Procedures utilizing stem cells have the potential to regenerate damaged heart tissue, improve heart function, and stimulate the repair of cardiac cells. In diseases including lupus and rheumatoid arthritis, sclerosis stem cell therapy can modify the disease process and restore immune balance. These cells can modulate T-cell responses and have been used to treat certain autoimmune diseases. For conditions such as osteoarthritis, muscular dystrophy, and other musculoskeletal disorders, stem cell therapy is promising for regenerating cartilage, bone, and muscle tissues. The treatment aims to reduce pain, improve function, and possibly delay or avoid the need for more invasive treatments like joint replacements. Stem cell therapy's potential to treat neurological disorders such as Alzheimer's is its capacity to protect, repair, or replace neurons and glial cells. Stem cells demonstrate a significant capacity to enhance the healing of wounds and injuries. By deploying MSCs in wound care, these cells can promote the regeneration of skin tissue, reduce scarring, and improve healing times. This is particularly relevant for burn victims, patients with diabetic ulcers, or individuals who experience slow wound healing.

End-User: Increasing uses of stem cell therapy in academics & research centers and hospitals offering effective, safe, and standardized treatment outcomes

Academic & research centers are crucial in advancing stem cell science and require various stem cell types to propel disease study, medication development, and therapy innovation breakthroughs. These institutions significantly contribute to pioneering studies and serve as a breeding ground for innovation in stem cell applications. On the other hand, ambulatory surgical centers (ASCs) provide a setting for certain types of outpatient stem cell therapies. These centers, less resource-intensive than hospitals, offer a cost-effective alternative for patients and insurers. Hospitals and clinics remain the primary care setting for the administration of stem cell therapies, particularly for more complex and acute medical conditions. The diverse patient population they serve creates a need for a broad range of stem cell therapies, including hematopoietic stem cell transplantation (HSCT) for diseases such as leukemia and lymphoma and various regenerative medicine applications. Biopharmaceutical companies are key players in the development and commercialization of stem cell therapies. They not only purchase stem cells for R&D purposes - working on new drug discoveries and development of regenerative medicine - but also for the purpose of manufacturing, where stem cell lines are used to produce therapeutic products at scale. Biopharma's interest in stem cell therapies corresponds with its ongoing search for innovative treatments that offer improved outcomes over existing medicines. Biopharmaceutical companies work on the development and commercialization of stem cell therapies. They purchase stem cells for R&D purposes to on new drug discoveries and the development of regenerative medicine and also for the purpose of manufacturing, where stem cell lines are used to produce therapeutic products at scale.

Regional Insights

In America, countries including the United States and Canada, advanced healthcare infrastructure and a high prevalence of chronic diseases have driven the need for innovative treatments such as stem cell therapy. The customer purchasing behavior reflects a greater propensity to adopt new healthcare technologies, particularly in areas such as regenerative medicine. Significant research investments and activity are evidenced by the region's major position in stem cell patents, which supports a robust and evolving therapy market. The European Union (EU) presents a diverse space for stem cell therapy, with countries including Germany, the UK, and France focusing on research and clinical applications. At the same time, the Middle East and Africa region is experiencing burgeoning interest in stem cell therapy with the huge investments in healthcare improvements and increased demand for advanced medical treatments. Initiatives such as the Dubai Cell Therapy and Regenerative Medicine Framework aim to position the region as a hub for medical tourism in stem cell therapy. Meanwhile, in Asia, countries such as China, Japan, and India reflect a rapidly expanding market for stem cell therapies, and the government's supportive policies have resulted in a flourishing environment for research and innovation. Japan's and China's progressive regulatory approach with the establishment of fast-track approval for regenerative medicine products has made these countries major spaces for stem cell therapy adoption. In India, growing healthcare infrastructure and increased public and private funding for research represent a shift towards greater usage and development of stem cell therapies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Stem Cell Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Stem Cell Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Fujifilm to Invest USD 200 Million in Cell Therapy Production

    Fujifilm Holdings Corporation is channeling a formidable USD 200 million investment into cell therapy manufacturing, anticipating substantial growth in this sector. This financial injection enhances the capabilities of two pivotal subsidiaries, Fujifilm Cellular Dynamics and Fujifilm Diosynth Biotechnologies. Fujifilm Cellular Dynamics is at the forefront of creating human-induced pluripotent stem cells and their derivatives. This investment underscores Fujifilm’s commitment to innovation and its foresight in the burgeoning field of advanced medical treatments. [Published On: 2023-12-06]

  • Mesoblast Enters Collaboration for SR-aGVHD Trial After FDA Rejections

    Mesoblast Limited, a frontrunner in regenerative medicine, announced a strategic collaboration with the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) to launch a pivotal clinical trial focused on Ryoncil (remestemcel-L), its innovative stem cell therapy. This trial is poised to assess the efficacy and safety of Ryoncil in treating steroid-refractory acute graft versus host disease (SR-aGvHD) in individuals aged 12 years and older. [Published On: 2023-11-23]

  • Selecta Biosciences Announces Merger with Cartesian Therapeutics

    Selecta Biosciences, Inc., a biotechnology firm, completed its merger with Cartesian Therapeutics, Inc., a significant contributor in RNA cell therapy for autoimmune diseases. This strategic merger positions the newly christened Cartesian Therapeutics, Inc. with a robust financial foundation, with a collective cash reserve of over USD 110 million. These funds are expected to accelerate Descartes-08, its RNA-engineered chimeric antigen receptor T-cell therapy (rCAR-T), through Phase 3 trials, offering a pioneering treatment for Myasthenia Gravis (MG). Moreover, the capital injection propelled the development of its expansive RNA cell therapy portfolio. [Published On: 2023-11-13]

Key Company Profiles

The report delves into recent significant developments in the Stem Cell Therapy Market, highlighting leading vendors and their innovative profiles. These include 4D Molecular Therapeutics, Inc., Anterogen Co., Ltd., Astellas Pharma Inc., Athersys, Inc., Aurion Biotechnologies, Beike Biotechnology Co., Ltd., BrainStorm Cell Therapeutics Inc., Bristol-Myers Squibb Company, CellProthera, Fate Therapeutics, Inc., Gamida Cell Ltd., Garuda Therapeutics, Holostem Terapie Avanzate S.r.l., Jasper Therapeutics, Inc., JCR Pharmaceuticals Co., Ltd., Juvena Therapeutics Inc., Kangstem Biotech., Ltd., Kite Pharma, Inc. by Gilead Sciences, Inc., Lineage Cell Therapeutics, Inc., Lonza Group AG, Mesoblast Ltd., Novo Nordisk A/S, Plasticell, ReNeuron Group PLC, Sartorius CellGenix GmbH, SQZ Biotechnologies Company, Takara Bio Inc., U.S. Stem Cell Inc, Umoja Biopharma, and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Stem Cell Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Allogeneic Stem Cell Therapy
    • Autologous Stem Cell Therapy
  • Cell Source
    • Adipose Tissue-Derived MSCs
    • Bone Marrow-Derived MSCs
    • Placental / Umbilical Cord-Derived MSCs
  • Therapeutic Application
    • Cardiovascular Diseases Surgeries
    • Inflammatory & Autoimmune Diseases
    • Musculoskeletal Disorders
    • Neurological Disorders
    • Orthopedics & Rheumatoid
    • Wounds & Injuries
  • End-User
    • Academic & Research Centers
    • Ambulatory Surgical Centers
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Clinics

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Stem Cell Therapy Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Stem Cell Therapy Market?
  3. What are the technology trends and regulatory frameworks in the Stem Cell Therapy Market?
  4. What is the market share of the leading vendors in the Stem Cell Therapy Market?
  5. Which modes and strategic moves are suitable for entering the Stem Cell Therapy Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Rising prevalence of degenerative diseases and cancer cases across the world
        2. Increasing government initiatives for stem cell therapy across the world
        3. Expansion of stem cell therapy centers and clinics
      2. Restraints
        1. Difficulties associated with performing stem cell therapy
      3. Opportunities
        1. Ongoing advancements in stem cell therapy
        2. Surging approvals for marketing and clinical trials for stem cell therapies and treatments
      4. Challenges
        1. Ethical and safety issues of stem cell-based therapy
    2. Market Segmentation Analysis
      1. Type: Increasing uses of allogeneic and autologous stem cell therapy in chronic disease treatments
      2. Cell Source: Rising adoption of AD-MSCs and BM-MSCs in tissue remodeling and tissue repairing
      3. Therapeutic Application: Growing popularity of regenerative medicine in varied therapeutics areas
      4. End-User: Increasing uses of stem cell therapy in academics & research centers and hospitals offering effective, safe, and standardized treatment outcomes
    3. Market Trend Analysis
      1. Rigorous stem cell therapy based research initiatives, evolving regulatory frameworks, and an increasing demand for advanced therapies is fueling market in Americas
      2. Advancements in stem cell therapies backed by government fundings and rising adoption due to medical tourism practices in the APAC countries
      3. Strong network of academic institutions and biotech firms backed by government funding to accelerate stem cell research and commercialization in EMEA
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Stem Cell Therapy Market, by Type
    1. Introduction
    2. Allogeneic Stem Cell Therapy
    3. Autologous Stem Cell Therapy
  7. Stem Cell Therapy Market, by Cell Source
    1. Introduction
    2. Adipose Tissue-Derived MSCs
    3. Bone Marrow-Derived MSCs
    4. Placental / Umbilical Cord-Derived MSCs
  8. Stem Cell Therapy Market, by Therapeutic Application
    1. Introduction
    2. Cardiovascular Diseases Surgeries
    3. Inflammatory & Autoimmune Diseases
    4. Musculoskeletal Disorders
    5. Neurological Disorders
    6. Orthopedics & Rheumatoid
    7. Wounds & Injuries
  9. Stem Cell Therapy Market, by End-User
    1. Introduction
    2. Academic & Research Centers
    3. Ambulatory Surgical Centers
    4. Biotechnology & Pharmaceutical Companies
    5. Hospitals & Clinics
  10. Americas Stem Cell Therapy Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Asia-Pacific Stem Cell Therapy Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  12. Europe, Middle East & Africa Stem Cell Therapy Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  13. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
      1. Fujifilm to Invest USD 200 Million in Cell Therapy Production
      2. Mesoblast Enters Collaboration for SR-aGVHD Trial After FDA Rejections
      3. Selecta Biosciences Announces Merger with Cartesian Therapeutics
      4. Takara Bio Enters into a License Agreement of RetroNectin with Fondazione Telethon ETS
      5. Bayer Opens First Cell Therapy Manufacturing Facility to Advance Regenerative Medicines on a Global Scale
      6. Novo Nordisk Foundation Invests USD 135 Million to Build Cell Therapy Plant
      7. BioLineRx Announces FDA Approval of APHEXDA (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Patients with Multiple Myeloma
      8. BlueRock Therapeutics and bit.bio Announce Collaboration and Option Agreement for the Discovery and Manufacture of Regulatory T Cell (Treg) based Therapies
      9. StemCyte Signs a Cooperation Agreement with a Cutting-edge U.S. immune Cell Therapy Company to Supply Drug Preparation Raw Materials for Allogeneic Modified Cell Therapy
      10. CIRM Invests USD 89 Million in Stem Cell and Gene Therapy Research
      11. Bristol Myers Squibb Strengthens Cell Therapy Capabilities by Adding New U.S. Manufacturing Facility for Viral Vector Production
      12. Novo Nordisk to Expand R&D Presence in Greater Boston Area
      13. Garuda Therapeutics Secures USD 62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform
      14. BioCardia and CellProthera Enhance Collaboration for Development of ProtheraCytes for the Treatment of Acute Myocardial Infarction in Europe and Potential Early Access for Patients
      15. ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Player in Regenerative Therapies
  14. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  15. List of Figures [Total: 24]
    1. STEM CELL THERAPY MARKET RESEARCH PROCESS
    2. STEM CELL THERAPY MARKET SIZE, 2023 VS 2030
    3. GLOBAL STEM CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. STEM CELL THERAPY MARKET DYNAMICS
    7. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    8. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2023 VS 2030 (%)
    10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
    12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    13. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    14. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    15. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    16. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    17. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    18. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    19. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    22. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    23. STEM CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
    24. STEM CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Tables [Total: 382]
    1. STEM CELL THERAPY MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL STEM CELL THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL STEM CELL THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    8. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    9. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    14. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    15. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MSCS, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MSCS, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BONE MARROW-DERIVED MSCS, BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BONE MARROW-DERIVED MSCS, BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PLACENTAL / UMBILICAL CORD-DERIVED MSCS, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PLACENTAL / UMBILICAL CORD-DERIVED MSCS, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    22. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    23. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES SURGERIES, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES SURGERIES, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INFLAMMATORY & AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INFLAMMATORY & AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
    30. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
    31. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ORTHOPEDICS & RHEUMATOID, BY REGION, 2018-2023 (USD MILLION)
    32. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ORTHOPEDICS & RHEUMATOID, BY REGION, 2024-2030 (USD MILLION)
    33. GLOBAL STEM CELL THERAPY MARKET SIZE, BY WOUNDS & INJURIES, BY REGION, 2018-2023 (USD MILLION)
    34. GLOBAL STEM CELL THERAPY MARKET SIZE, BY WOUNDS & INJURIES, BY REGION, 2024-2030 (USD MILLION)
    35. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    36. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    37. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2023 (USD MILLION)
    38. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2024-2030 (USD MILLION)
    39. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
    40. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
    41. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
    42. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
    43. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
    44. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
    45. AMERICAS STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    46. AMERICAS STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    47. AMERICAS STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    48. AMERICAS STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    49. AMERICAS STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    50. AMERICAS STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    51. AMERICAS STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    52. AMERICAS STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    53. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    54. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    55. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    56. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    57. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    58. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    59. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    60. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    61. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    62. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    63. BRAZIL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    64. BRAZIL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    65. BRAZIL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    66. BRAZIL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    67. BRAZIL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    68. BRAZIL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    69. BRAZIL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    70. BRAZIL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    71. CANADA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    72. CANADA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    73. CANADA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    74. CANADA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    75. CANADA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    76. CANADA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    77. CANADA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    78. CANADA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    79. MEXICO STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    80. MEXICO STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    81. MEXICO STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    82. MEXICO STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    83. MEXICO STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    84. MEXICO STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    85. MEXICO STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    86. MEXICO STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    87. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    88. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    89. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    90. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    91. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    92. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    93. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    94. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    95. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    96. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    97. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    98. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    99. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    100. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    101. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    102. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    103. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    104. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    105. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    106. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    107. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    108. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    109. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    110. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    111. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    112. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    113. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    114. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    115. CHINA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    116. CHINA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    117. CHINA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    118. CHINA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    119. CHINA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    120. CHINA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    121. CHINA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    122. CHINA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    123. INDIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    124. INDIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    125. INDIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    126. INDIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    127. INDIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    128. INDIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    129. INDIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    130. INDIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    131. INDONESIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    132. INDONESIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    133. INDONESIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    134. INDONESIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    135. INDONESIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    136. INDONESIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    137. INDONESIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    138. INDONESIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    139. JAPAN STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    140. JAPAN STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    141. JAPAN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    142. JAPAN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    143. JAPAN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    144. JAPAN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    145. JAPAN STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    146. JAPAN STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    147. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    148. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    149. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    150. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    151. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    152. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    153. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    154. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    155. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    156. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    157. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    158. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    159. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    160. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    161. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    162. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    163. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    164. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    165. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    166. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    167. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    168. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    169. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    170. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    171. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    172. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    173. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    174. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    175. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    176. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    177. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    178. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    179. TAIWAN STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    180. TAIWAN STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    181. TAIWAN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    182. TAIWAN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    183. TAIWAN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    184. TAIWAN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    185. TAIWAN STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    186. TAIWAN STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    187. THAILAND STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    188. THAILAND STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    189. THAILAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    190. THAILAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    191. THAILAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    192. THAILAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    193. THAILAND STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    194. THAILAND STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    195. VIETNAM STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    196. VIETNAM STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    197. VIETNAM STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    198. VIETNAM STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    199. VIETNAM STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    200. VIETNAM STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    201. VIETNAM STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    202. VIETNAM STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    203. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    204. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    205. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    206. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    207. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    208. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    209. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    210. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    211. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    212. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    213. DENMARK STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    214. DENMARK STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    215. DENMARK STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    216. DENMARK STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    217. DENMARK STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    218. DENMARK STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    219. DENMARK STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    220. DENMARK STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    221. EGYPT STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    222. EGYPT STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    223. EGYPT STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    224. EGYPT STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    225. EGYPT STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    226. EGYPT STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    227. EGYPT STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    228. EGYPT STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    229. FINLAND STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    230. FINLAND STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    231. FINLAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    232. FINLAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    233. FINLAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    234. FINLAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    235. FINLAND STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    236. FINLAND STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    237. FRANCE STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    238. FRANCE STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    239. FRANCE STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    240. FRANCE STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    241. FRANCE STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    242. FRANCE STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    243. FRANCE STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    244. FRANCE STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    245. GERMANY STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    246. GERMANY STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    247. GERMANY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    248. GERMANY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    249. GERMANY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    250. GERMANY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    251. GERMANY STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    252. GERMANY STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    253. ISRAEL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    254. ISRAEL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    255. ISRAEL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    256. ISRAEL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    257. ISRAEL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    258. ISRAEL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    259. ISRAEL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    260. ISRAEL STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    261. ITALY STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    262. ITALY STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    263. ITALY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    264. ITALY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    265. ITALY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    266. ITALY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    267. ITALY STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    268. ITALY STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    269. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    270. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    271. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    272. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    273. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    274. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    275. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    276. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    277. NIGERIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    278. NIGERIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    279. NIGERIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    280. NIGERIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    281. NIGERIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    282. NIGERIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    283. NIGERIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    284. NIGERIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    285. NORWAY STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    286. NORWAY STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    287. NORWAY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    288. NORWAY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    289. NORWAY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    290. NORWAY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    291. NORWAY STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    292. NORWAY STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    293. POLAND STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    294. POLAND STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    295. POLAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    296. POLAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    297. POLAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    298. POLAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    299. POLAND STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    300. POLAND STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    301. QATAR STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    302. QATAR STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    303. QATAR STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    304. QATAR STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    305. QATAR STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    306. QATAR STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    307. QATAR STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    308. QATAR STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    309. RUSSIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    310. RUSSIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    311. RUSSIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    312. RUSSIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    313. RUSSIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    314. RUSSIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    315. RUSSIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    316. RUSSIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    317. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    318. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    319. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    320. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    321. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    322. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    323. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    324. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    325. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    326. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    327. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    328. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    329. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    330. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    331. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    332. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    333. SPAIN STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    334. SPAIN STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    335. SPAIN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    336. SPAIN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    337. SPAIN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    338. SPAIN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    339. SPAIN STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    340. SPAIN STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    341. SWEDEN STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    342. SWEDEN STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    343. SWEDEN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    344. SWEDEN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    345. SWEDEN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    346. SWEDEN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    347. SWEDEN STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    348. SWEDEN STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    349. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    350. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    351. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    352. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    353. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    354. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    355. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    356. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    357. TURKEY STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    358. TURKEY STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    359. TURKEY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    360. TURKEY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    361. TURKEY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    362. TURKEY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    363. TURKEY STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    364. TURKEY STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    365. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    366. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    367. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    368. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    369. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    370. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    371. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    372. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    373. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    374. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    375. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2023 (USD MILLION)
    376. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024-2030 (USD MILLION)
    377. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
    378. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
    379. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    380. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    381. STEM CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
    382. STEM CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
  17. List of Companies Mentioned [Total: 30]
    1. 4D Molecular Therapeutics, Inc.
    2. Anterogen Co., Ltd.
    3. Astellas Pharma Inc.
    4. Athersys, Inc.
    5. Aurion Biotechnologies
    6. Beike Biotechnology Co., Ltd.
    7. BrainStorm Cell Therapeutics Inc.
    8. Bristol-Myers Squibb Company
    9. CellProthera
    10. Fate Therapeutics, Inc.
    11. Gamida Cell Ltd.
    12. Garuda Therapeutics
    13. Holostem Terapie Avanzate S.r.l.
    14. Jasper Therapeutics, Inc.
    15. JCR Pharmaceuticals Co., Ltd.
    16. Juvena Therapeutics Inc.
    17. Kangstem Biotech., Ltd.
    18. Kite Pharma, Inc. by Gilead Sciences, Inc.
    19. Lineage Cell Therapeutics, Inc.
    20. Lonza Group AG
    21. Mesoblast Ltd.
    22. Novo Nordisk A/S
    23. Plasticell
    24. ReNeuron Group PLC
    25. Sartorius CellGenix GmbH
    26. SQZ Biotechnologies Company
    27. Takara Bio Inc.
    28. U.S. Stem Cell Inc
    29. Umoja Biopharma
    30. Vericel Corporation
Frequently Asked Questions
  1. How big is the Stem Cell Therapy Market?
    Ans. The Global Stem Cell Therapy Market size was estimated at USD 439.83 million in 2023 and expected to reach USD 493.23 million in 2024.
  2. What is the Stem Cell Therapy Market growth?
    Ans. The Global Stem Cell Therapy Market to grow USD 1,027.44 million by 2030, at a CAGR of 12.88%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.